Literature DB >> 21234729

The role of uric acid as an endogenous danger signal in immunity and inflammation.

Faranak Ghaemi-Oskouie1, Yan Shi.   

Abstract

Gout is an ancient disease that still plagues us. Its pathogenic culprit, uric acid crystal deposition in tissues, is a strong inflammatory stimulant. In recent years, the mechanisms through which uric acid crystals promote inflammation have been a subject of increasing interest among rheumatologists and immunologists. Uric acid has been identified as an endogenous adjuvant that drives immune responses in the absence of microbial stimulation. Because uric acid is a ubiquitous metabolite that is produced in high quantities upon cellular injury, the ramifications of its effects may be considerable in health and in disease. Uric acid crystals also have been shown to trigger interleukin-1β-mediated inflammation via activation of the NOD-like receptor protein (NLRP)3 inflammasome, a multimolecular complex whose activation appears to be central to many pathological inflammatory conditions. In this article, we review the possible mechanisms of uric acid-mediated inflammation and offer some historical perspectives on what has been learned about the complex effects of a relatively simple substance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21234729      PMCID: PMC3093438          DOI: 10.1007/s11926-011-0162-1

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  42 in total

1.  Role of the leucine-rich repeat domain of cryopyrin/NALP3 in monosodium urate crystal-induced inflammation in mice.

Authors:  Hal M Hoffman; Peter Scott; James L Mueller; Amir Misaghi; Sean Stevens; George D Yancopoulos; Andrew Murphy; David M Valenzuela; Ru Liu-Bryan
Journal:  Arthritis Rheum       Date:  2010-07

2.  Crystal-induced neutrophil activation. VII. Involvement of Syk in the responses to monosodium urate crystals.

Authors:  P Desaulniers; M Fernandes; C Gilbert; S G Bourgoin; P H Naccache
Journal:  J Leukoc Biol       Date:  2001-10       Impact factor: 4.962

3.  Molecular identification of a renal urate anion exchanger that regulates blood urate levels.

Authors:  Atsushi Enomoto; Hiroaki Kimura; Arthit Chairoungdua; Yasuhiro Shigeta; Promsuk Jutabha; Seok Ho Cha; Makoto Hosoyamada; Michio Takeda; Takashi Sekine; Takashi Igarashi; Hirotaka Matsuo; Yuichi Kikuchi; Takashi Oda; Kimiyoshi Ichida; Tatsuo Hosoya; Kaoru Shimokata; Toshimitsu Niwa; Yoshikatsu Kanai; Hitoshi Endou
Journal:  Nature       Date:  2002-04-14       Impact factor: 49.962

Review 4.  Pathogenesis of crystal-induced inflammation.

Authors:  R C Landis; D O Haskard
Journal:  Curr Rheumatol Rep       Date:  2001-02       Impact factor: 4.592

5.  Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells.

Authors:  Gilbert Ng; Karan Sharma; Sandra M Ward; Melanie D Desrosiers; Leslie A Stephens; W Michael Schoel; Tonglei Li; Clifford A Lowell; Chang-Chun Ling; Matthias W Amrein; Yan Shi
Journal:  Immunity       Date:  2008-11-14       Impact factor: 31.745

6.  Is uric acid protective or deleterious in acute ischemic stroke? A prospective cohort study.

Authors:  Raymond C S Seet; Katherine Kasiman; Jan Gruber; Soon-Yew Tang; Meng-Cheong Wong; Hui-Meng Chang; Yiong-Huak Chan; Barry Halliwell; Christopher P Chen
Journal:  Atherosclerosis       Date:  2009-08-14       Impact factor: 5.162

Review 7.  Uric acid and cardiovascular risk.

Authors:  Daniel I Feig; Duk-Hee Kang; Richard J Johnson
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245

8.  Serum urate during acute gout.

Authors:  Naomi Schlesinger; Josephine M Norquist; Douglas J Watson
Journal:  J Rheumatol       Date:  2009-04-15       Impact factor: 4.666

Review 9.  Update on gout: new therapeutic strategies and options.

Authors:  Robert Terkeltaub
Journal:  Nat Rev Rheumatol       Date:  2010-01       Impact factor: 20.543

10.  Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity.

Authors:  Susumu Watanabe; Duk-Hee Kang; Lili Feng; Takahiko Nakagawa; John Kanellis; Hui Lan; Marilda Mazzali; Richard J Johnson
Journal:  Hypertension       Date:  2002-09       Impact factor: 10.190

View more
  70 in total

1.  Significance analysis of xMap cytokine bead arrays.

Authors:  Joong-Ho Won; Ofir Goldberger; Shai S Shen-Orr; Mark M Davis; Richard A Olshen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-09       Impact factor: 11.205

Review 2.  Inflammasomes and metabolic disorders: old genes in modern diseases.

Authors:  Gregory R Robbins; Haitao Wen; Jenny P-Y Ting
Journal:  Mol Cell       Date:  2014-04-24       Impact factor: 17.970

Review 3.  Innate and adaptive immune responses to cell death.

Authors:  Kenneth L Rock; Jiann-Jyh Lai; Hajime Kono
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

Review 4.  Innate immunity and the failing heart: the cytokine hypothesis revisited.

Authors:  Douglas L Mann
Journal:  Circ Res       Date:  2015-03-27       Impact factor: 17.367

Review 5.  Managing Gout in the Patient with Renal Impairment.

Authors:  Eliseo Pascual; Francisca Sivera; Mariano Andrés
Journal:  Drugs Aging       Date:  2018-04       Impact factor: 3.923

6.  Efficacy and safety of febuxostat in patients with hyperuricemia and gout.

Authors:  Ignacio Garcia-Valladares; Tahir Khan; Luis R Espinoza
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-10       Impact factor: 5.346

Review 7.  Graft rejection - endogenous or allogeneic?

Authors:  William R Critchley; James E Fildes
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

8.  Leukocyte infiltration and activation of the NLRP3 inflammasome in white adipose tissue following thermal injury.

Authors:  Mile Stanojcic; Peter Chen; Rachael A Harrison; Vivian Wang; Jeremy Antonyshyn; Juan Carlos Zúñiga-Pflücker; Marc G Jeschke
Journal:  Crit Care Med       Date:  2014-06       Impact factor: 7.598

9.  Hyperuricemia has an adverse impact on the prognosis of patients with osteosarcoma.

Authors:  Shangzeng Wang; Xiaoya Liu; Zike He; Xinfeng Chen; Wei Li
Journal:  Tumour Biol       Date:  2015-08-18

10.  No evidence for involvement of the toll-like receptor (TLR) 4 gene Asp299Gly and Thr399Ile polymorphisms in susceptibility to primary gouty arthritis.

Authors:  Yu-Feng Qing; Jing-Guo Zhou; Ming Li; Wen-Guang Xie; Cui-Ping Huang; Sheng-Ping Zeng; Ling Yin
Journal:  Rheumatol Int       Date:  2012-11-15       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.